Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• ForscherInnen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: FIBRINOLYSIS, . Treffer: 44

2020

Posch, F; Hofer, S; Thaler, J; Hell, L; Königsbrügge, O; Grilz, E; Mauracher, LM; Gebhart, J; Marosi, C; Jilma, B; Pabinger, I; Ay, C Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.
Transl Res. 2020; 215: 41-56. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Rief, M; Zajic, P; Zoidl, P; Heschl, S; Silbernagel, G; Orlob, S; Prattes, G; Metnitz, P; Prause, G Patient disposition following cardiopulmonary resuscitation due to ST-segment elevation myocardial infarction and thrombolysis-case report Which factors influence the choice of transport destination?
NOTFALL RETTUNGSMED. 2019; 22(6): 528-532. [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

2018

Malle, EM; Posch-Pertl, L; Renner, W; Pinter-Hausberger, S; Singer, C; Haas, A; Wedrich, A; Weger, M Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
Ophthalmic Genet. 2018; 39(6): 714-716.
Web of Science PubMed FullText FullText_MUG

 

2017

Pabinger, I; Fries, D; Schöchl, H; Streif, W; Toller, W Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.
Wien Klin Wochenschr. 2017; 129(9-10):303-316 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Hell, L; Thaler, J; Martinod, K; Ay, C; Posch, F; Wagner, DD; Pabinger, I OC-16 - Neutrophil extracellular traps and tissue factor-bearing microvesicles: a liaison dangereuse causing overt DIC in cancer patients?
Thromb Res. 2016; 140 Suppl 1(1):S174-S175
Web of Science PubMed FullText FullText_MUG

 

2015

Chennamsetty, I; Scharnagl, H; Kleber, ME; Marz, W; Kostner, GM Lipoprotein(a): when to measure and how to treat?
LABORATORIUMSMEDIZIN. 2015; 39(2): 71-80. [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Delgado, GE; Siekmeier, R; Krämer, BK; März, W; Kleber, ME Plasma Fibrinolysis Parameters in Smokers and Non-smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Adv Exp Med Biol. 2015; 858(4):69-77
Web of Science PubMed FullText FullText_MUG

 

Gebhart, J; Laczkovics, C; Posch, F; Ay, C; Reitter-Pfoertner, SE; Haslacher, H; Muszbek, L; Wolberg, AS; Pabinger, I Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause.
Ann Hematol. 2015; 94(8): 1301-1310.
Web of Science PubMed FullText FullText_MUG

 

2014

Huang, J; Huffman, JE; Yamkauchi, M; Trompet, S; Asselbergs, FW; Sabater-Lleal, M; Tregouet, DA; Chen, WM; Smith, NL; Kleber, ME; Shin, SY; Becker, DM; Tang, WH; Dehghan, A; Johnson, AD; Truong, V; Folkersen, L; Yang, Q; Oudot-Mellkah, T; Buckley, BM; Moore, JH; Williams, FMK; Campbell, H; Silbernagel, G; Vitart, V; Rudan, I; Tofler, GH; Navis, GJ; DeStefano, A; Wright, AF; Chen, MH; de Craen, AJM; Worrall, BB; Rudnicka, AR; Rumley, A; Bookman, EB; Psaty, BM; Chen, F; Keene, KL; Franco, OH; Bohm, BO; Uitterlinden, AG; Carter, AM; Jukema, JW; Sattar, N; Bis, JC; Ikram, MA; Sale, MM; McKnight, B; Fornage, M; Ford, I; Taylor, K; Slagboom, PE; McArdle, WL; Hsu, FC; Franco-Cereceda, A; Goodall, AH; Yanek, LR; Furie, KL; Cushman, M; Hofman, A; Witteman, JCM; Folsom, AR; Basu, S; Matijevic, N; van Gilst, WH; Wilson, JF; Westendorp, RGJ; Kathiresan, S; Reilly, MP; Tracy, RP; Polasek, O; Winkelmann, BR; Grant, PJ; Hillege, HL; Cambien, F; Stott, DJ; Lowe, GD; Spector, TD; Meigs, JB; Marz, W; Eriksson, P; Becker, LC; Morange, PE; Soranzo, N; Williams, SM; Hayward, C; van der Harst, P; Hamsten, A; Lowenstein, CJ; Strachan, DP; O'Donnell, CJ; Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2.
ARTERIOSCLER THROMB VASC BIOL. 2014; 34(5): 1093-1101. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Lu, J; Roth, RA; Malle, E; Ganey, PE Roles of the hemostatic system and neutrophils in liver injury from co-exposure to amiodarone and lipopolysaccharide.
Toxicol Sci. 2013; 136(1):51-62 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Chennamsetty, I; Claudel, T; Kostner, KM; Trauner, M; Kostner, GM FGF19 signaling cascade suppresses APOA gene expression.
Arterioscler Thromb Vasc Biol. 2012; 32(5):1220-1227 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schaden, E; Kimberger, O; Kraincuk, P; Baron, DM; Metnitz, PG; Kozek-Langenecker, S Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements.
Br J Anaesth. 2012; 109(3):376-381 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Fries, D; Innerhofer, P; Perger, P; Gutl, M; Heil, S; Hofmann, N; Kneifel, W; Neuner, L; Pernerstorfer, T; Pfanner, G; Schochl, H; Ziegler, B; Kolblinger, C; Kozek-Langenecker, S Coagulation management in trauma-related massive bleeding. - Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI)
Anasthesiol Intensivmed Notfallmed Schmerzther. 2010; 45(9):552-561
Web of Science PubMed FullText FullText_MUG

 

Yazdani-Biuki, B; Krippl, P; Brickmann, K; Fuerst, F; Langsenlehner, U; Paulweber, B; Pilger, E; Wascher, TC; Brezinschek, HP; Renner, W The functional promoter polymorphism of the coagulation factor XII gene is not associated with peripheral arterial disease.
Angiology. 2010; 61(2):211-215
Web of Science PubMed FullText FullText_MUG

 

2007

Binder, A; Endler, G; Müller, M; Mannhalter, C; Zenz, W; European Meningococcal Study Group 4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia.
J Thromb Haemost. 2007; 5(10):2049-2054 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2006

Worel, N; Schulenburg, A; Mitterbauer, M; Keil, F; Rabitsch, W; Kalhs, P; Gisslinger, H; Raderer, M; Geissler, K; Höcker, P; Zielinski, CC; Oberbauer, R; Greinix, HT Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
Wien Klin Wochenschr. 2006; 118(1-2): 49-53.
Web of Science PubMed FullText FullText_MUG

 

2005

Geishofer, G; Binder, A; Müller, M; Zöhrer, B; Resch, B; Müller, W; Faber, J; Finn, A; Endler, G; Mannhalter, C; Zenz, W; Central European Meningococcal Genetic Study Group 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.
Eur J Pediatr. 2005; 164(8):486-490
Web of Science PubMed FullText FullText_MUG

 

Rothenbacher, D; Brenner, H; März, W; Koenig, W Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
Eur Heart J. 2005; 26(16):1640-1646 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2003

von Campe, G; Regli, F; Bogousslavsky, J Heralding manifestations of basilar artery occlusion with lethal or severe stroke.
J Neurol Neurosurg Psychiatry. 2003; 74(12): 1621-1626. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wakabayashi, I; Groschner, K Vascular actions of anthracycline antibiotics.
Curr Med Chem. 2003; 10(5):427-436
Web of Science PubMed FullText FullText_MUG

 

2002

Jilma, B; Marsik, C; Mayr, F; Graninger, MT; Taylor, FB; Ribel, MC; Erhardtsen, E; Handler, S; Eichler, HG Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
Clin Pharmacol Ther. 2002; 72(4):403-410
Web of Science PubMed FullText FullText_MUG

 

2001

Stanger, O; Weger, M; Renner, W; Konetschny, R Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
Clin Chem Lab Med. 2001; 39(8):725-733
Web of Science PubMed FullText FullText_MUG

 

Sudi, KM; Gallistl, S; Tröbinger, M; Payerl, D; Weinhandl, G; Muntean, W; Aigner, R; Borkenstein, MH The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents.
J Pediatr Endocrinol Metab. 2001; 14(1):85-94
Web of Science PubMed Google Scholar

 

2000

Renner, W; Köppel, H; Brodmann, M; Pabst, E; Schallmoser, K; Toplak, H; Wascher, TC; Pilger, E Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.
THROMB HAEMOST. 2000; 83: 20-22.
Web of Science PubMed

 

Schenk, P; Rosenkranz, AR; Wolfl, G; Horl, WH; Traindl, O Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath.
Am J Kidney Dis. 2000; 35(1):130-136
Web of Science PubMed FullText FullText_MUG

 

1999

Roller, RE; Janisch, S; Carroll, V; Kvas, E; Pilger, E; Binder, BR; Wojta, J Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty.
Thromb Res. 1999; 94(4):241-247
Web of Science PubMed FullText FullText_MUG

 

1998

Gallistl, S; Mangge, H; Neuwirth, G; Muntean, W Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity.
Thromb Res. 1998; 92(6):267-272
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Wedrich, A; Menapace, R; Ries, E; Polzer, I Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.
J CATARACT REFRACT SURG 1997 23: 873-877.
Web of Science PubMed FullText FullText_MUG

 

1995

Frank, S; Durovic, S; Kostner, K; Kostner, GM Inhibitors for the in vitro assembly of Lp(a).
Arterioscler Thromb Vasc Biol. 1995; 15(10):1774-1780 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1994

Salat, C; Holler, E; Reinhardt, B; Kolb, HJ; Pihusch, R; Neumeister, P; Hiller, E Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation
Med Klin (Munich). 1994; 89(5): 245-247.
Web of Science PubMed

 

Wedrich, A; Menapace, R; Mühlbauer-Ries, E The use of recombinant tissue plasminogen activator for intracameral fibrinolysis following cataract surgery.
INT OPHTHALMOL 1994 18: 277-280.
Web of Science PubMed

 

1992

Flueckiger, F; Lammer, J; Klein, GE; Hausegger, K; Pilger, E; Waltner, F; Aschauer, M Percutaneous transluminal angioplasty of crural arteries.
Acta Radiol. 1992; 33(2):152-155
Web of Science PubMed Google Scholar

 

Hausegger, KA; Lammer, J; Hagen, B; Flückiger, F; Lafer, M; Klein, GE; Pilger, E Iliac artery stenting--clinical experience with the Palmaz stent, Wallstent, and Strecker stent.
Acta Radiol. 1992; 33(4):292-296
Web of Science PubMed Google Scholar

 

1991

Hausegger, KA; Lammer, J; Klein, GE; Flückiger, F; Lafer, M; Pilger, E; Aschauer, M Percutaneous recanalization of pelvic artery occlusions--fibrinolysis, PTA, stents
FORTSCHR RONTGENSTRAHL NEUEN. 1991; 155(6): 550-555.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

März, W; Trommlitz, M; Scharrer, I; Gross, W Apolipoprotein (a) concentrations are not related to the risk of venous thrombosis.
Blood Coagul Fibrinolysis. 1991; 2(5):595-599
Web of Science PubMed Google Scholar

 

1989

Watzke, HH; Linkesch, W; Hay, U Giant hemangioma of the liver (Kasabach-Merritt syndrome): successful suppression of intravascular coagulation permitting surgical removal.
J Clin Gastroenterol. 1989; 11(3):347-350 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1988

Karàdi, I; Kostner, GM; Gries, A; Nimpf, J; Romics, L; Malle, E Lipoprotein (a) and plasminogen are immunochemically related.
Biochim Biophys Acta. 1988; 960(1):91-97
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Lammer, J; Karnel, F Percutaneous transluminal laser angioplasty with contact probes.
Radiology. 1988; 168(3):733-737
Web of Science PubMed FullText FullText_MUG

 

1986

Lammer, J; Pilger, E; Neumayer, K; Schreyer, H Intraarterial fibrinolysis: long-term results.
RADIOLOGY. 1986; 161(1): 159-163.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Pilger, E; Lammer, J; Bertuch, H; Steiner, H Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
Radiology. 1986; 161(3):597-599
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1985

Lammer, J; Pilger, E; Justich, E; Neumayer, K; Schreyer, H Fibrinolysis in chronic arteriosclerotic occlusions: intrathrombotic injections of streptokinase. Work in progress.
Radiology. 1985; 157(1):45-50
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Sailer, S; Pilger, E Fibrinolytic therapy of peripheral arterial occlusive disease
WIEN MED WOCHENSCHR. 1985; 135(15-16): 393-399.
Web of Science PubMed

 

1984

Pilger, E Acute peripheral ischemia syndrome
WIEN MED WOCHENSCHR. 1984; 134(13-14): 311-315. (- Case Report)
Web of Science PubMed

 

1980

Muntean, W Haemostasis in premature and newborn babies (author's transl)
PADIATR PADOL. 1980; 15(2): 109-120.
Web of Science PubMed

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum